Alvarez & Marsal
600 Madison Avenue 8th Floor, New York, NY, 10022, United States
Overview
Alvarez & Marsal provides advisory services related to turnaround management and performance improvement for high profile businesses. It provides turnaround management, corporate restructuring and performance improvement for companies and stakeholders. It provides leadership, problem-solving' and value-creation services to motivate and build underperforming and robust companies across the industry spectrum. Alvarez & Marsal has assisted high profile businesses such as Lehman Brothers, HealthSouth, Tribune Company, Warnaco, Interstate bakeries, and Arthur Andersen. It was established in 1983 by Tony Alvarez II and Bryan Marsal. It is based in São Paulo, Brazil. It has additional offices in Canada, China, India, U.A.E, Netherlands, the United States, and in the United Kingdom.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 8
Sector focus
- Consulting
- Professional Services
Investment portfolio
- BIOWEG
Participated · Series A · Sep 2025
Founded in 2019 by Dr Prateek Mahalwar and Srinivas Karuturi, BIOWEG uses precision fermentation to transform food-industry waste into high-purity bacterial cellulose and related bio-based acids. These ingredients power product lines such as Micbeads (micro-powders), RheoWeg (rheology modifiers) and AgriWeg (seed and fertiliser coatings) that replace microplastics and fossil-derived polymers in personal care, home care and agriculture. The same fermentation platform is now being extended, together with TU Berlin, to create a low-energy, solvent-free, water-based method for selectively recovering rare earth elements from complex waste streams. BIOWEG operates a demonstration site in Quakenbrück, Germany, and an applications lab on Bayer Crop Science’s campus in Monheim. The company’s process integrates in-house-produced bio-acids for bioleaching with TU Berlin’s peptide-based separation columns, aiming to deliver a circular solution for Europe’s growing REE demand. Its approach targets lower CO₂ footprints, reduced toxic waste and improved economic viability compared with conventional, high-energy REE recovery. The latest €1.5 million funding strengthens BIOWEG’s balance sheet and accelerates scale-up of the REE platform alongside its existing commercial ingredient lines.